• Pregnenolone Carbonitrile: Designing Better PXR Assays

  2026-08-10

  Pregnenolone Carbonitrile is a powerful rodent PXR agonist for connecting CYP3A induction, xenobiotic metabolism, and antifibrotic biology. This guide focuses on assay design, orthogonal validation, tissue-specific interpretation, and the emerging hypothalamic–kidney findings that broaden PCN research beyond the liver.

• Intestinal TM6SF2, MASH, and the Gut–Liver Axis

  2026-08-09

  A 2025 Nature Metabolism study shows that intestinal epithelial TM6SF2 protects against MASH by preserving barrier function and constraining microbiota- and lipid-mediated signaling to the liver. Genetic deletion, fecal transplantation, cohousing, transcriptomics, and pharmacological intervention together identify LPA movement from the gut as a mechanistic link between intestinal lipid handling and hepatic inflammation.

• Calpeptin and EV Release in Triple-Negative Breast Cancer

  2026-08-08

  The reference study systematically tested pharmacological strategies for suppressing extracellular vesicle release from triple-negative breast cancer cells and examined whether residual vesicles retained functional effects. Its central contribution is the combination of quantitative vesicle profiling with recipient-cell migration assays, showing that broad suppression of vesicle output may be necessary to substantially limit the transfer of aggressive traits.

• Octenidine dihydrochloride: Lab Workflows

  2026-08-07

  Build reproducible antimicrobial assays around Octenidine dihydrochloride, from solvent selection and serial dilution to membrane-disruption and biofilm readouts. Use the compound as a defined benchmark while translating recent gemini-QAC findings into smarter comparative screens for potency, selectivity, and formulation.

• Hexetidine (NSC-17764): Applied Workflows for Antimicrobial

  2026-08-07

  Hexetidine (NSC-17764) stands out for its proven efficacy against oral pathogens and biofilm-forming fungi, with robust, reproducible results in both planktonic and biofilm inhibition assays. This article delivers actionable protocol guidance, troubleshooting insights, and workflow enhancements for researchers seeking high-confidence, strain-specific antimicrobial data.

• KIR2.1 Inhibition Reduces PASMC Proliferation via TGF-β/Smad

  2026-08-06

  This study demonstrates that KIR2.1 enhances proliferation and migration of pulmonary artery smooth muscle cells (PASMCs) by activating the TGF-β1/Smad2/3 pathway, implicating its role in pulmonary vascular remodeling. By employing both a KIR2.1 blocker and the ALK5 inhibitor SB 431542, the authors reveal mechanistic insights relevant for pulmonary hypertension research and highlight potential therapeutic strategies targeting this axis.

• Arachidonic Acid Supplementation Accelerates Humoral Immunit

  2026-08-06

  The referenced study demonstrates that dietary arachidonic acid (ARA) supplementation can significantly enhance and accelerate the production of neutralizing antibodies following rabies vaccination in mice and humans. These findings reveal new mechanistic insight into how polyunsaturated fatty acids, such as ARA, can modulate B cell activation and suggest dietary strategies for improving vaccine efficacy.

• Promethazine HCl: Driving Innovation in Immunometabolic Rese

  2026-08-05

  This thought-leadership article explores Promethazine HCl’s unique role as a mechanistic probe in immunology and inflammation research. By synthesizing recent mechanistic findings and translational strategy, it provides translational researchers with actionable insights for leveraging this phenothiazine derivative to interrogate host-pathogen interactions, macrophage biology, and beyond. The piece stands apart by connecting fundamental histamine receptor antagonism with emerging host-directed therapeutic paradigms, offering a critical resource for advanced research teams.

• Moxidectin Synergizes with Polyenes Against Oral Candidiasis

  2026-08-05

  This study reveals that moxidectin, a macrocyclic lactone anthelmintic, enhances the antifungal efficacy of polyenes against Candida albicans by upregulating ergosterol biosynthesis. These findings offer a new mechanistic strategy to combat oral candidiasis, particularly in drug-resistant or high-risk populations.

• HyperFluor™ 594 Goat Anti-Rabbit IgG Antibody: Precision in

  2026-08-04

  Unlock high-fidelity immunofluorescence and immunohistochemistry with the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody. This advanced fluorophore-conjugated reagent drives sensitive, reproducible detection of rabbit IgG targets—empowering atherosclerosis research and beyond with unmatched spectral clarity and protocol flexibility.

• Ruxolitinib Phosphate (INCB018424): JAK/STAT Pathway Modulat

  2026-08-04

  Ruxolitinib phosphate is a potent, selective JAK1/JAK2 inhibitor (IC50: 3 nM/5 nM) widely used for cytokine signaling inhibition and rheumatoid arthritis research. Recent studies reveal its unique mechanism in inducing apoptosis and pyroptosis in anaplastic thyroid carcinoma cells via suppression of DRP1-mediated mitochondrial fission, highlighting new research avenues for autoimmune and neoplastic disease models.

• MK-0812: Redefining CCR2 Inhibition in Experimental MASH Mod

  2026-08-03

  Explore how MK-0812, a potent CCR2 antagonist, is revolutionizing monocyte trafficking studies in MASH research. This article delivers advanced insights into assay design, mechanistic application, and the translational impact of MK-0812 distinct from existing guides.

• Olanzapine Enhances Early Brain Maturation via NODAL/FOXH1 P

  2026-08-03

  This study leverages human iPSC-derived cerebral organoids to reveal that olanzapine, at therapeutic doses, accelerates early neuronal maturation by activating the NODAL/FOXH1 axis. These findings clarify the molecular basis for olanzapine's effects on human neurodevelopment and establish a model for dissecting neuropsychiatric drug safety in early brain formation.

• Tofacitinib Restores Mitochondrial Function in RA Macrophage

  2026-08-02

  The reference study demonstrates that tofacitinib (CP-690550) uniquely reverses GM-CSF-driven inflammation and mitochondrial dysregulation in RA macrophages by targeting STAT5 signaling. These findings highlight an innovative mechanism of immune modulation with direct implications for advanced cytokine signaling blockade and metabolic correction protocols in translational research.

• Transmission Dynamics of Carbapenemase Genes in CREC, Guangd

  2026-08-01

  This study provides a detailed molecular characterization of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong during 2022–2024. By integrating genotypic, phenotypic, and epidemiological analyses, the research reveals high rates of multidrug resistance and dominant plasmid-mediated gene dissemination, with significant implications for antimicrobial resistance surveillance and infection control.

544 records 8/37 page Previous Next First page 上5页 678910 下5页 Last page